NTI 5.80% 7.3¢ neurotech international limited

Ann: Trading Halt, page-57

  1. 6,419 Posts.
    lightbulb Created with Sketch. 688
    To KGDN, you can still watch it.

    Ma420
    He spoke a lot about the neuren model. It's obvious that they want a partner.
    And he pretty much dismissed FDA approval. He specifically said they are focussing on Australia.

    And (not his exact words) but if they can get 'special approval' they are looking at 18 months for product approval.
    But he did point out something I had pondered. A possible requirement for another trial being requested by the TGA.

    Also note: and this goes back to a previous suggestion by you. They are not looking for orphan approval in ASD.
    As I said, they won't get it.

    The market is just too big. Go read up on typical approvals for orphan status applications.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.3¢
Change
0.004(5.80%)
Mkt cap ! $74.26M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $14.43K 199.5K

Buyers (Bids)

No. Vol. Price($)
1 60162 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 66000 1
View Market Depth
Last trade - 14.01pm 26/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.